All Posts

Semaglutide and tirzepatide can significantly improve insulin resistance, hormones, and weight in women with PCOS. Learn what clinical research shows—and whether these medications may be right for you.

Weight loss is not about willpower—it’s about biology. Learn why your body fights weight loss, why diets fail long-term, and how medical treatments like GLP-1 and GIP medications help you lose weight safely and sustainably.

If you’re comparing  Zepbound (tirzepatide, GLP-1/GIP) vs. Wegovy (semaglutide, GLP-1)  for weight loss, you’re not alone. These two medications are the most effective  weight-loss injections  available today — and both can help you lose significant weight safely under physician supervision. This guide breaks down how each medication works, how they differ, which one produces more weight loss, what side effects to expect, and how to choose the option that fits your goals, bud

Do you have to stay on semaglutide or tirzepatide forever to keep the weight off? Not necessarily—but understanding how these GLP-1 and GLP-1/GIP medications work explains why some people benefit from long-term or maintenance therapy. Potere Health MD, serving St George, Cedar City, and Salt Lake City Utah, offers physician-led, evidence-based guidance to help you maintain lasting results safely and confidently.

GLP-1 and GLP-1/GIP medications like semaglutide and tirzepatide don’t cause true muscle wasting. Most weight lost is fat, not muscle. Learn how proper protein intake and resistance training preserve lean mass and support healthy body composition during GLP-1 therapy.

Oral semaglutide (Wegovy® tablets) is now FDA-approved for chronic weight management. This once-daily 25 mg pill uses the same active ingredient as injectable Wegovy®, offering a needle-free option for patients who can’t tolerate injections or prefer a daily tablet. Learn how it works, how it compares to Wegovy® injections, and what this new approval means for access, dosing, and real-world weight-loss results.

Excess fat lowers testosterone and raises estrogen. This evidence-based article explains how weight loss can restore balance and what studies show about tirzepatide and TRT, including benefits and side effects.

Wegovy (semaglutide) is now FDA-approved for MASH with fibrosis (F2–F3) in adults. See what this means for treatment, eligibility, and weight management.

Zepbound (tirzepatide) is the first FDA-approved medication for obstructive sleep apnea in adults with obesity. Learn how it works and who may benefit.

Wondering if Zepbound or Wegovy is right for you? Learn how they compare for weight loss, safety, and insurance coverage in Utah.

Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD As of 2026, compounded semaglutide and tirzepatide are no longer broadly permitted in the United States. Following resolution of nationwide shortages, the FDA ended its temporary enforcement discretion, meaning these medications may now only be compounded under  limited, legally defined circumstances .¹–³ On  February 21, 2025 , the  U.S. Food and Drug Administration  formally declared the

Worried about hair loss while taking Wegovy®, Ozempic® (semaglutide), Zepbound®, or Mounjaro® (tirzepatdie)? Learn why shedding happens during weight loss and how to prevent it.

Learn how the FDA Green List impacts compounded semaglutide and tirzepatide. Understand Import Alert 66-80, patient safety, and what it does not mean.

Wegovy (semaglutide) is FDA-approved to reduce major heart risks in adults with obesity/overweight and cardiovascular disease. Learn what it means and who qualifies.